Incidence rate of type 1 diabetes in Santiago (Chile) by HLA-DQA1 and DQB1 genotypes

European Journal of Epidemiology

Volumn 18, Issue 8, 2003, Pages 787-792

  Diaz N ^a   Mendez M A ^a   Perez Bravo F ^a   Carrasco, E ^a   Santos, José L ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Diabetes; HLA DQ genotypes; Incidence

Indexed keywords

HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; RISK FACTOR;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHILE; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; INCIDENCE; LOGISTIC MODELS; PREDICTIVE VALUE OF TESTS; REGISTRIES;

EID: 17044456024     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025345804789     Document Type: Article

References (25)

1. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428-1436.
2. Dorman JS, McCarthy B, McCanlies E, et al. and the WHO DiaMond Molecular Epidemiology Sub-Project Group. Molecular IDDM epidemiology: International studies. Diabetes Res Clin Pract 1996; 34: S107-S116.
3. Ronningen KS, Keiding N, Green A. Correlations between the incidence of childhood-onset type 1 diabetes in Europe and HLA genotypes. Diabetologia 2001; 44(Suppl 3): B51-B59.
4. Nejentsev S, Koskinen S, Sjoroos M, et al. Distribution of insulin-dependent diabetes mellitus (IDDM)-related HLA alleles correlates with the difference in IDDM incidence in four populations of the Eastern Baltic region. Tissue Antigens 1998; 52: 473-477.
5. Carrasco E, Mondragón A, Santos JL, Perez F. Incidence of type 1 diabetes mellitus under 15 years in Santiago, Chile 1993-1997. Diab Res Clin Pract 2000; 50(Suppl 1): S-120.
6. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers. Diabetes 1997; 46: 1701-1710.
7. Hahl J, Simell T, Ilonen J, Knip M, Simell O. Costs of predicting IDDM. Diabetologia 1998; 41: 79-85.
8. Kupila A, Muona P, Simell T, et al. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 2001; 44: 290-297.
9. Rewers M, Bugawan TL, Norris JM, et al. Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the young (DAISY). Diabetologia 1996; 39: 807-812.
10. Santos JL, Carrasco E, Moore AL, Pérez-Bravo F, Albala C. Incidence rate and spatio-temporal clustering of type 1 diabetes in Santiago, Chile, from 1997 to 1998. Revista de Saúde Pública 2001; 35: 96-100.
11. Santos JL, Pérez-Bravo F, Carrasco E, Calvillán M, Albala C. Association between HLA-DQB1 alleles and type 1 diabetes in a case-parents study conducted in Santiago, Chile. Am J Epidemiol 2001; 153: 794-798.
12. Pérez-Bravo F, Carrasco E, Gutierrez-Lopez MD, Martinez MT, Lopez G, de los Rios MG. Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chile. J Mol Med 1996; 74: 105-109.
13. Santos-Martín JL, Pérez-Bravo F, Carrasco E, Albala C. Different statistical models used in the calculation of the prevalence of insulin dependent diabetes mellitus according to the polymorphisms of HLA-DQ region. Immuno Cell Biol 1997; 75: 351-355.
14. Perez-Bravo F, Riesco MV, Albala C, Oyarzun A, Santos JL, Carrasco E. Perfil de auto-anticuerpos y lactancia materna en pacientes diabéticos tipo 1. Rev Med Chile 2001; 129: 611-619.
15. Dorman JS, Bunker CH. HLA-DQ locus of the Human leukocyte antigen complex and type 1 diabetes mellitus: A Huge review. Am J Epidemiol 2000; 22: 218-227.
16. McCullagh P, Neider JA. Generalized Linear Models. 2nd ed., London: Chapman and Hall, 1991.
17. Neutra RR, Drolette ME. Estimating exposure-specific disease rates from case-control studies using Bayes' theorem. Am J Epidemiol 1978; 108: 214-222.
18. Undlien DE, Lie BA, Thorsby E. HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trend Genet 2001; 17: 93-100.
19. Ilonen J, Sjoroos M, Knip M, et al. Estimation of genetic risk for type 1 diabetes. Am J Med Genet 2002; 115: 30-36.
20. Santos JL, Schaid D, Pérez-Bravo F, et al. Applicability of the case-parent design in the etiological research of type 1 diabetes in Chile and other genetically mixed populations. Diab Res Clin Pract 1999; 43: 143-146.
21. Cruz-Coke R. Origen y evolución étnica de la población Chilena. Rev Med Chile 1976; 104: 365-368.
22. Green A, Gale EAM, Patterson CC for the EURODIAB ACE Study Group. Incidence of childhood-onset insulin-dependent diabetes mellitus: The EURODIAB ACE study. Lancet 1992; 339: 905-909.
23. Bell J. The new genetics in clinical practice. Br Med J 1998; 316: 618-620.
24. Vineis P, Schulte P, McMichael AJ. Misconceptions about the use of genetic test in populations. The Lancet 2001; 357: 709-712.
25. Pietropaolo M, Becker DJ. Type I diabetes intervention trials. Pediatric Diab 2001; 2: 2-11.